A study of clinical outcome and safety profile of Remdesivir in COVID-19 patients in a tertiary care centre
Introduction: COVID 19 disease has wrecked a havoc as pandemic in the entire world. It causes cardiac manifestations, digestive system disturbances, and adversely affecting other organs. As a result, ardent efforts are underway to find effective antiviral treatments targeting possible mechanisms to...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Al Ameen Medical College
2022-01-01
|
| Series: | Al Ameen Journal of Medical Sciences |
| Subjects: | |
| Online Access: | http://ajms.alameenmedical.org/ArticlePDFs/8%20AJMS%20V15.N1.2022%20p%2032-37.pdf |
| _version_ | 1831703680206766080 |
|---|---|
| author | Fariha Fatima Fardan Qadeer Afroz Abidi Zeba Siddiqui Dilshad A Rizvi Akhlaque Ahmad |
| author_facet | Fariha Fatima Fardan Qadeer Afroz Abidi Zeba Siddiqui Dilshad A Rizvi Akhlaque Ahmad |
| author_sort | Fariha Fatima |
| collection | DOAJ |
| description | Introduction: COVID 19 disease has wrecked a havoc as pandemic in the entire world. It causes cardiac manifestations, digestive system disturbances, and adversely affecting other organs. As a result, ardent efforts are underway to find effective antiviral treatments targeting possible mechanisms to identify a specific medication for the disease to curb its progression and to prevent patients sufferings, one such therapy being injectable antiviral treatment namely, Remdesivir. Objectives: To evaluate the clinical outcomes and safety profile of Remdesivir in COVID-19 patients in a tertiary care center. Methods: An observational retrospective cohort study was planned with sample size of 210 patients suffering from active moderate to severe COVID 19 disease admitted in a single center tertiary care hospital requiring injectable anti-viral therapy that is Remdesivir. Patient data was collected from the case record forms. Primary outcomes in terms of length of hospital stay, duration of treatment with Remdesivir, survival rate in patients on Remdesivir and assessment of the days for the COVID 19 positive test to eventually become negative in patients and secondary outcome in terms of safety were evaluated. Results: There was a clinically significant improvement in the SPO2 levels from the time of admission till discharge. The appearance of adverse effects was taken as the secondary outcome. Hepatic and renal toxicity was observed after completion of treatment whereas no immunological abnormalities were observed. Conclusion: Until stronger evidences come to the fore, we cannot derive substantial inference that our injectable antiviral therapy drug namely, Remdesivir is efficacious for treating COVID-19. |
| first_indexed | 2024-12-20T15:45:36Z |
| format | Article |
| id | doaj.art-3b7a79b177fd43dda4b823535a651876 |
| institution | Directory Open Access Journal |
| issn | 0974-1143 |
| language | English |
| last_indexed | 2024-12-20T15:45:36Z |
| publishDate | 2022-01-01 |
| publisher | Al Ameen Medical College |
| record_format | Article |
| series | Al Ameen Journal of Medical Sciences |
| spelling | doaj.art-3b7a79b177fd43dda4b823535a6518762022-12-21T19:34:59ZengAl Ameen Medical CollegeAl Ameen Journal of Medical Sciences0974-11432022-01-0115013237A study of clinical outcome and safety profile of Remdesivir in COVID-19 patients in a tertiary care centreFariha Fatima0Fardan Qadeer1Afroz Abidi2Zeba Siddiqui3Dilshad A Rizvi4Akhlaque Ahmad5Department of Pharmacology, Era’s Lucknow Medical College and Hospital, Sarfarazganj, Hardoi Road, Lucknow-226003 Uttar Pradesh, IndiaDepartment of Pharmacology, Era’s Lucknow Medical College and Hospital, Sarfarazganj, Hardoi Road, Lucknow-226003 Uttar Pradesh, IndiaDepartment of Pharmacology, Era’s Lucknow Medical College and Hospital, Sarfarazganj, Hardoi Road, Lucknow-226003 Uttar Pradesh, IndiaDepartment of General Medicine, Era’s Lucknow Medical College and Hospital Sarfarazganj, Hardoi Road, Lucknow-226003 Uttar Pradesh, IndiaDepartment of Pharmacology, Era’s Lucknow Medical College and Hospital, Sarfarazganj, Hardoi Road, Lucknow-226003 Uttar Pradesh, IndiaDepartment of Pharmacology, Era’s Lucknow Medical College and Hospital, Sarfarazganj, Hardoi Road, Lucknow-226003 Uttar Pradesh, IndiaIntroduction: COVID 19 disease has wrecked a havoc as pandemic in the entire world. It causes cardiac manifestations, digestive system disturbances, and adversely affecting other organs. As a result, ardent efforts are underway to find effective antiviral treatments targeting possible mechanisms to identify a specific medication for the disease to curb its progression and to prevent patients sufferings, one such therapy being injectable antiviral treatment namely, Remdesivir. Objectives: To evaluate the clinical outcomes and safety profile of Remdesivir in COVID-19 patients in a tertiary care center. Methods: An observational retrospective cohort study was planned with sample size of 210 patients suffering from active moderate to severe COVID 19 disease admitted in a single center tertiary care hospital requiring injectable anti-viral therapy that is Remdesivir. Patient data was collected from the case record forms. Primary outcomes in terms of length of hospital stay, duration of treatment with Remdesivir, survival rate in patients on Remdesivir and assessment of the days for the COVID 19 positive test to eventually become negative in patients and secondary outcome in terms of safety were evaluated. Results: There was a clinically significant improvement in the SPO2 levels from the time of admission till discharge. The appearance of adverse effects was taken as the secondary outcome. Hepatic and renal toxicity was observed after completion of treatment whereas no immunological abnormalities were observed. Conclusion: Until stronger evidences come to the fore, we cannot derive substantial inference that our injectable antiviral therapy drug namely, Remdesivir is efficacious for treating COVID-19.http://ajms.alameenmedical.org/ArticlePDFs/8%20AJMS%20V15.N1.2022%20p%2032-37.pdfretrospectivecohortcovidpandemicclinical outcomeanti-viral agentsremdesivirspo2 |
| spellingShingle | Fariha Fatima Fardan Qadeer Afroz Abidi Zeba Siddiqui Dilshad A Rizvi Akhlaque Ahmad A study of clinical outcome and safety profile of Remdesivir in COVID-19 patients in a tertiary care centre Al Ameen Journal of Medical Sciences retrospective cohort covid pandemic clinical outcome anti-viral agents remdesivir spo2 |
| title | A study of clinical outcome and safety profile of Remdesivir in COVID-19 patients in a tertiary care centre |
| title_full | A study of clinical outcome and safety profile of Remdesivir in COVID-19 patients in a tertiary care centre |
| title_fullStr | A study of clinical outcome and safety profile of Remdesivir in COVID-19 patients in a tertiary care centre |
| title_full_unstemmed | A study of clinical outcome and safety profile of Remdesivir in COVID-19 patients in a tertiary care centre |
| title_short | A study of clinical outcome and safety profile of Remdesivir in COVID-19 patients in a tertiary care centre |
| title_sort | study of clinical outcome and safety profile of remdesivir in covid 19 patients in a tertiary care centre |
| topic | retrospective cohort covid pandemic clinical outcome anti-viral agents remdesivir spo2 |
| url | http://ajms.alameenmedical.org/ArticlePDFs/8%20AJMS%20V15.N1.2022%20p%2032-37.pdf |
| work_keys_str_mv | AT farihafatima astudyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT fardanqadeer astudyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT afrozabidi astudyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT zebasiddiqui astudyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT dilshadarizvi astudyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT akhlaqueahmad astudyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT farihafatima studyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT fardanqadeer studyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT afrozabidi studyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT zebasiddiqui studyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT dilshadarizvi studyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre AT akhlaqueahmad studyofclinicaloutcomeandsafetyprofileofremdesivirincovid19patientsinatertiarycarecentre |